Penfluridol Tablets
Penfluridolum by the Hunan Pharmaceutical Co., Ltd. first production, the quality of the upper, award-winning:
1982 was rated as outstanding new products in Hunan Province
1983 was named the outstanding new products in Hunan Province Golden Dragon Award
1986 was rated as quality products in Hunan Province
In 1988 won the national first disease nemesis contest gold medal
1992 won the "National Award for clinical application of the award-winning product evaluation" trustworthy drug award.
Penfluridolum - Clinical application describes:
Features: long-lasting, efficient, simple and economical;
Oral: warm water delivery service, but also on the food with the service;
Long-term; only served once a week, efficacy up to 7 days;
Efficient: the effect is equivalent to such as chlorphenzhen 20 times;
Economy: the price is cheaper, a patient can spend just a few dollars a month can cure.
And only once a week, eliminating the daily medication trouble.
Penfluridolum - Purpose and scope of therapy
1, the clinical types of schizophrenia;
2, chronic schizophrenia;
3, the use of other antipsychotic efficacy is not significant or ineffective schizophrenia;
4, the consolidation of schizophrenia and maintenance therapy;
5, medication does not cooperate with schizophrenia;
6, urban and rural areas in the treatment of schizophrenia;
7, on a variety of delusions, the disorder of the mental state has a good role in the adjustment;
8, can eliminate suspicion and auditory hallucinations, emotional stability;
9, to ease the emotional behavior disorder, to improve the relationship between the surrounding interpersonal, to restore sensible.
Penfluridol Tablets brochure
[Drug name] generic name: Penfluridol Tablets
Product name: Penfluridol Tablets
Pinyin: Wufuliduo Pian
Ingredients This product is active ingredient Penfluridolum.
Chemical name: 1- [4.4- bis (4-fluorophenyl) butyl] -4- [4-chloro-3-
(Trifluoromethyl) phenyl] -4-piperidinol.
Molecular formula: C28H27CIF5NO
Molecular weight: 523.97
[Properties] This product is sugar-coated tablets, remove the coating was white or white, for the treatment of various types of schizophrenia, more suitable for maintenance of patients with remission.
[Specification] 20mg
Dosage orally.
Treatment dose range of 1 to 6 tablets, once a week.
Should be 0.5 to 1 tablet per week began to gradually increase, each week or two weeks to increase 0.5 to 1, to reduce the extrapyramidal reaction.
Usually the amount of treatment for a week 1.5 to 3, to disappear with the original dose of symptoms continue to consolidate 3 months to maintain the dose of 0.5 to 1 week.
Adverse reactions mainly for extrapyramidal reactions, such as meditation can not, acute dystonia and Parkinson's disease.
Long-term use can occur in a variety of late dyskinesia, can also occur drowsiness, fatigue, dry mouth, menstrual disorders, galactorrhea, anxiety or depression and so on.
Occasional allergic rash, ECG abnormalities, neutropenia and malignant syndrome.
Taboo basal ganglia disease, Parkinson's disease, Parkinson's disease, bone marrow suppression and patients allergic to the chemicals were banned.
[Note] (1) liver and kidney dysfunction with caution.
(2) liver function and white blood cell count should be checked regularly.
Do not drive vehicles, operate machinery or aerial work during medication.
Pregnant women and lactating women medication pregnant women with caution.
Breastfeeding women should stop breastfeeding during the use of this product.
[Child medication] prone to extrapyramidal reaction, depending on the discretion of the amount of reduction.
[Elderly medication] prone to extrapyramidal reaction, depending on the discretion to reduce the amount.
[Drug interactions] This product and ethanol or other central nervous system inhibitors, central inhibition increased.
This product is combined with antihypertensive drugs, there is the risk of increased orthostatic hypotension, this product and other antipsychotic drugs, there is the risk of extrapyramidal reaction.
[Drug overdose] poisoning symptoms: the main toxic effects of myocardial damage and interference in the heart conduction, severe arrhythmia, chest tightness, suffocation and so on.
Treatment: This product is a long time, excessive poisoning should be careful not to pay attention to symptomatic treatment and supportive therapy, no special antidote.
[Drug Toxicology] This product is oral long-acting antipsychotics.
Antipsychotic effect and its blocking the brain dopamine receptor, but also can block the nervous system α-adrenergic receptor, antipsychotic effect of strong and lasting, oral once can be maintained for several days to a week, also have antiperspirant effect, but calm The role of weak, less impact on cardiovascular function.
Pharmacokinetics: oral absorption is slow, 24-27 hours of plasma concentration peak, 7 days after the blood can still be detected.
Absorbed after storage in adipose tissue, slow release, and gradually penetrate into the brain tissue.
Most of the prototype from the feces, a small amount of urine excreted.
[Storage] sealed.
[Packing] solid medicinal plastic bottles, 20mg * 24 tablets / bottle.
[Validity] 36 months [the implementation of standards] "Chinese Pharmacopoeia" 2015 version of the second [approval number] GYZZ H43021061
[Manufacturer] Company Name: Hunan Middle-South Pharmaceutical Co., Ltd.
Production Address: Longxutang, Shaoxing City, Hunan Province, China
Post code: 422001
Phone number: +86-739-5270030 5270119
Fax number: +86-739-5271610
